(Q42919438)

11 November 2017

Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics (English)

1 reference

11 November 2017

0 references

Birol Emir

1

1 reference

11 November 2017

Thomas Kevin Murphy

series ordinal

2

1 reference

11 November 2017

Danielle Lauren Petersel

series ordinal

3

1 reference

11 November 2017

Ed Whalen

series ordinal

4

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Pharmacotherapy

11 November 2017

1 reference

11 November 2017

11

1 reference

11 November 2017

14

1 reference

11 November 2017

2275-2280

1 reference

Understanding fibromyalgia: lessons from the broader pain research community

11 November 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Fibromyalgia: harmonizing science with clinical practice considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Treatment options and patient perspectives in the management of fibromyalgia: future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Narrative review: the pathophysiology of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Pregabalin for fibromyalgia: some relief but no cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.509717

10.1517/14656566.2010.509717

21 January 2018

Identifiers

DOI

1 reference

11 November 2017

1 reference